CompletedPhase 2NCT00786305
Nebulized Ceftazidime and Amikacin in Ventilator Associated Pneumonia
Studying Pneumonia caused by Pseudomonas aeruginosa infection
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Groupe Hospitalier Pitie-Salpetriere
- Principal Investigator
- Jean-Jacques Rouby, MD, PhDLa Pitie-Salpetriere hospital
- Intervention
- ceftazidime and amikacin(drug)
- Enrollment
- 40 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2004 – 2008
Study locations (1)
- Intensive care unit, Department of anesthesiology, La pitie-Salpetriere hospital, Paris, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00786305 on ClinicalTrials.govOther trials for Pneumonia caused by Pseudomonas aeruginosa infection
Additional recruiting or active studies for the same condition.
See all trials for Pneumonia caused by Pseudomonas aeruginosa infection →